Barriers to coliphage infection of commensal intestinal flora of laboratory mice

Virology Journal

Volumn 2, Issue , 2005, Pages

  Kasman, Laura M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIOPHAGE LAMBDA; BACTERIOPHAGE TYPING; COLIPHAGE; DIET; ESCHERICHIA COLI; FECES ANALYSIS; GASTROINTESTINAL TRACT; HOST SUSCEPTIBILITY; IMMUNITY; INTESTINE FLORA; LYSOGENIZATION; MOUSE; NONHUMAN; SERUM;

ANIMALS; COLIPHAGES; ESCHERICHIA COLI; FECES; FEMALE; INTESTINAL MUCOSA; LYSOGENY; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, NUDE;

ANIMALIA; ESCHERICHIA COLI;

EID: 21544454112     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-2-34     Document Type: Article

References (16)

1. Sulakvelidze A, Alavidze Z, Morris JGJ: Bacteriophage therapy. Antimicrob Agents Chemother 2001, 45:649-659.
2. Weber-Darbrowska B, Dabrowski S: Studies on bacteriophage penetration in patients subjected to phage therapy. Arch Immunol Ther Exper 1987, 35:563-568.
3. Berchieri AJ, Lovell MA, Barrow PA: The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res Microbiol 1991, 142:541-549.
4. Boyd JSK, Portnoy B: Bacteriophage therapy in bacillary dysentery. Trans R Soc Trop Med Hyg 1944, 37:243-262.
5. Delmastro P, Meola A, Monaci P, Cortese R, Galfre G: Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine 1997, 15:1276-1285.
6. Smith HW, Huggins MB, Shaw KM: The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 1987, 133:1111-1126.
7. Bogovazova GG, Voroshilova NN, Bondarenko VM: [The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection]. Zh Mikrobiol Epidemiol Immunobiol 1991:5-8.
8. Ando A, Furuse K, Watanabe I: Propagation of ribonucleic acid coliphages in gnotobiotic mice. Appl Environ Microbiol 1979, 37:1157-1165.
9. Zuercher AW, S. M. Miescher, M. Vogel, M. P. Rudolf, M. B. Stadler, Stadler. BM: Oral anti-IgE immunization with epitopr displaying phage. Eur J Immunol 2000, 30:128-135.
10. Waldor MK, Mekalanos JJ: Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996, 272:1910-1914.
11. Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, Norris JS: Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob Agents Chemother 2003, 47:1301-1307.
12. Kasman LM, Kasman A, Westwater C, Dolan J, Schmidt MG, Norris JS: Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J Virol 2002, 76:5557-5564.
13. Savage DC: Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977, 31:107-133.
14. Smith HW: Survival of orally administered E. coli K12 in alimentary tract of man. Nature 1975, 255:500-502.
15. Leclerc H, Edberg S, Pierzo V, Delattre JM: Bacteriophages as indicators of enteric viruses and public health risk in groundwaters. J Appl Microbiol 2000, 88:5-21.
16. EPA Document 821-R-00-009 (April 2000 Draft) Method 1601: Male Specific (F+) and Somatic Coliphage in Water by Two-step Enrichment Procedure. 2000.